Sudarshan Chemical Industries (506655) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
9 Sep, 2026Executive summary
Consolidated Q3 FY26 results reflect continued market softness, with both legacy and acquired businesses experiencing lower revenues and profitability compared to the previous quarter and year-over-year.
Unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December 2025 were approved, reflecting the impact of a major acquisition and regulatory changes.
The group completed the acquisition of Heubach Group's global pigment business in March 2025, significantly expanding its international footprint.
Integration of acquired group progressing, with SAP system harmonization and cost-saving initiatives underway.
Customer destocking and high inventory levels persist, but early signs of demand recovery are visible in January and February.
Financial highlights
Q3 FY26 consolidated revenue from operations was ₹2,103 Cr, down from ₹2,387 Cr in Q2 FY26, but up from ₹666.4 Cr in Q3 FY25 due to the Heubach acquisition.
Adjusted EBITDA for Q3 FY26 was ₹40 Cr (1.9% margin), compared to ₹116 Cr (4.9% margin) in Q2 FY26; consolidated EBITDA was ₹37.9 Cr for Q3 FY26.
Q3 FY26 PBT before exceptional items was ₹30 Cr, with reported PBT at -₹77 Cr due to a ₹46 Cr impact from the new labour code.
Consolidated net loss for Q3 FY26 was ₹116 Cr, compared to a profit of ₹0.5 Cr in Q3 FY25; nine-month consolidated net loss was ₹41.7 Cr.
Exceptional items included a statutory impact of new Labour Codes and acquisition-related costs.
Outlook and guidance
Management expects the worst of the downturn is over, with customer trust returning and destocking easing.
Revised FY26 business EBITDA outlook for the acquired group is ~€16 Mn, down from earlier €25 Mn guidance.
Q4 FY26 expected to see positive sales momentum and ongoing value capture, but reported EBITDA may be temporarily lower due to inventory reduction.
Financial results for the period include the impact of the Heubach acquisition and are not comparable with previous periods.
The group continues to monitor regulatory developments and expects further adjustments as final rules on labour codes are clarified.
Latest events from Sudarshan Chemical Industries
- Revenue and margins rose, with normalized profit and improved financial strength.506655
Q1 24/25 - Acquisition creates a global pigment leader with 19 sites and accretive financials.506655
M&A announcement - Record revenue and profit growth, margin expansion, and major global acquisition approved.506655
Q2 24/25 - Record revenue and profit growth in Q3/9M FY25, with strong pigment exports and acquisition-driven expansion.506655
Q3 24/25 - Heubach acquisition drove strong revenue and EBITDA growth, but net profit declined on costs.506655
Q4 24/25 - Q1 FY26 sales reached ₹2,507 Cr and EBITDA rose, but margins and net profit ratio declined.506655
Q1 25/26 - Pigments-led growth and Heubach acquisition drove higher revenue, with integration costs impacting profit.506655
Q2 25/26 - Record revenue and EBITDA growth achieved, with Heubach integration and debt reduction progressing.506655
Q4 25/26 - Q1 FY27 saw robust revenue, profit, and EBITDA growth, with ongoing integration and restructuring.506655
Q1 26/27